Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting: A Pilot Randomized Clinical Trial
Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting: A Pilot Randomized Clinical Trial
复制标题
DOI：
10.1001/jamanetworkopen.2023.26127
复制
发表时间：
2023
影响因子：
13.8
通讯作者：
Yi-Jun Hua
中科院分区：
文献类型：
--
作者：
Qi Yang;Xiong Zou;Yu-Long Xie;Chao Lin;Yan-Feng Ouyang;Yong-Long Liu;Chong-Yang Duan;Rui You;You-Ping Liu;Rong-Zeng Liu;Pei-Yu Huang;Ling Guo;Yi-Jun Hua;Yi-Jun Hua
